AYTU BIOPHARMA, INC Earnings Per Share Diluted

Quick Answer

AYTU BIOPHARMA, INC reported Earnings Per Share Diluted of $5.11 (loss) per share for the year ending 2023.

  • AYTU BIOPHARMA, INC showed an increase of +93.1% in Earnings Per Share Diluted from 2022 to 2023.
  • This data is from AYTU BIOPHARMA, INC's annual report (Form 10-K), filed with the SEC on October 12, 2023.
  • XBRL data for this metric is available from 2021 to 2023 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2021 to 2023), AYTU BIOPHARMA, INC's Earnings Per Share Diluted has declined by 46.8%.
  • Historical annual values: Fiscal year 2023: $5.11 (loss) per share | Fiscal year 2022: $74.01 (loss) per share | Fiscal year 2021: $3.48 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: